Inventor · disambiguated record
Mark Eddleston
Also filed as: EDDLESTON MARK · EDDLESTON MARK D
10 granted patents·5 pending applications·71 citations·filing 2007–2019
88Inventor score
Top patents by PatentIndex Score
15 records- 0193US8669279B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2013·Granted Mar 11, 2014·17 cites·22 claims
- 0292US8883836B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2014·Granted Nov 11, 2014·12 cites·22 claims
- 0389US8076366B2Forms of bendamustine free baseCOURVOISIER LAURENT D·Filed 2010·Granted Dec 13, 2011·35 cites·33 claims
- 0487US9533955B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2016·Granted Jan 3, 2017·4 cites·12 claims
- 0582US8653064B2Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin-2-yl]amino}-2-methoxybenzoateARMITAGE Ian·Filed 2011·Granted Feb 18, 2014·3 cites·20 claims
- 0674US2020323824A1Novel solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2019·Application pending·0 cites
- 0770US10517852B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2018·Granted Dec 31, 2019·0 cites·1 claims
- 0868US2009264488A1Novel solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2009·Application pending·0 cites
- 0966US2015051258A1Novel Solid Forms Of Bendamustine HydrochlorideCEPHALON INC·Filed 2014·Application pending·0 cites
- 1065US10039750B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2016·Granted Aug 7, 2018·0 cites·8 claims
- 1163US2014357622A1Crystalline forms of sodium 4--2-methoxybenzoateMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 1258US10017513B2Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-D][2]benzazepin-2-YL]amino}-2-methoxybenzoateMILLENNIUM PHARM INC·Filed 2016·Granted Jul 10, 2018·0 cites·26 claims
- 1353US7872109B2Motilide polymorphsLICARI PETER J·Filed 2007·Granted Jan 18, 2011·0 cites·5 claims
- 1443US8030282B2Motilide polymorphsLICARI PETER J·Filed 2010·Granted Oct 4, 2011·0 cites·10 claims
- 1532US2011086891A1Solid Forms of 2-(2,4-Difluorophenyl)-6-(1-(2,6-Difluorophenyl)Ureido)Nicotinamide)VERTEX PHARMA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Eddleston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →